darunavir has been researched along with eprosartan in 3 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (eprosartan) | Trials (eprosartan) | Recent Studies (post-2010) (eprosartan) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 297 | 83 | 49 |
| Protein | Taxonomy | darunavir (IC50) | eprosartan (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.65 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dey, SR; Dutta Chowdhury, K; Haldar, R; Paul, A; Paul, SK | 1 |
1 review(s) available for darunavir and eprosartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for darunavir and eprosartan
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Exploring the possibility of drug repurposing for cancer therapy targeting human lactate dehydrogenase A: a computational approach.
Topics: Cell Line, Tumor; Darunavir; Drug Repositioning; Humans; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Molecular Docking Simulation; Moxalactam; Neoplasms | 2023 |